ARDELYX INC revenue for the last year amounted to 302.99 M CHF, the most of which — 302.99 M CHF — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 104.78 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought ARDELYX INC 289.89 M CHF, and the year before that — 70.11 M CHF.